<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34764200</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2021-001041</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Post-COVID-19 complications require simultaneous characterisation and management to plan policy and health system responses. We describe the 12-month experience of the first UK dedicated post-COVID-19 clinical service to include hospitalised and non-hospitalised patients.</AbstractText><AbstractText Label="METHODS">In a single-centre, observational analysis, we report the demographics, symptoms, comorbidities, investigations, treatments, functional recovery, specialist referral and rehabilitation of 1325 individuals assessed at the University College London Hospitals post-COVID-19 service between April 2020 and April 2021, comparing by referral route: posthospitalised (PH), non-hospitalised (NH) and post emergency department (PED). Symptoms associated with poor recovery or inability to return to work full time were assessed using multivariable logistic regression.</AbstractText><AbstractText Label="RESULTS">1325 individuals were assessed (PH: 547, 41.3%; PED: 212, 16%; NH: 566, 42.7%). Compared with the PH and PED groups, the NH group were younger (median 44.6 (35.6-52.8) years vs 58.3 (47.0-67.7) years and 48.5 (39.4-55.7) years), more likely to be female (68.2%, 43.0% and 59.9%), less likely to be of ethnic minority (30.9%, 52.7% and 41.0%) or seen later after symptom onset (median (IQR): 194 (118-298) days, 69 (51-111) days and 76 (55-128) days; all p&lt;0.0001). All groups had similar rates of onward specialist referral (NH 18.7%, PH 16.1% and PED 18.9%, p=0.452) and were more likely to require support for breathlessness (23.7%, 5.5% and 15.1%, p&lt;0.001) and fatigue (17.8%, 4.8% and 8.0%, p&lt;0.001). Hospitalised patients had higher rates of pulmonary emboli, persistent lung interstitial abnormalities and other organ impairment. 716 (54.0%) individuals reported &lt;75% optimal health (median 70%, IQR 55%-85%). Less than half of employed individuals could return to work full time at first assessment.</AbstractText><AbstractText Label="CONCLUSION">Post-COVID-19 symptoms were significant in PH and NH patients, with significant ongoing healthcare needs and utilisation. Trials of interventions and patient-centred pathways for diagnostic and treatment approaches are urgently required.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prashar</LastName><ForeName>Jai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillman</LastName><ForeName>Toby E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Department, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livingston</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridsdale</LastName><ForeName>Heidi A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Central and North West London NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2199-2638</Identifier><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zandi</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Alisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denneny</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astin</LastName><ForeName>Ronan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purcell</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attree</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UKDoctors#Longcovid, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hishmeh</LastName><ForeName>Lyth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Long COVID SOS, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prescott</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Central Lancashire, Preston, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Puja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Ewen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeremy S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porter</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logan</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Francis Crick Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehbi</LastName><ForeName>Hakim-Moulay</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cone</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK ami.banerjee@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_20022</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMJ Open Respir Res. 2022 Jan;9(1):e001041corr1. doi: 10.1136/bmjresp-2021-001041corr1</RefSource><PMID Version="1">35064008</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008913" MajorTopicYN="N">Minority Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">clinical epidemiology</Keyword></KeywordList><CoiStatement>Competing interests: AB has received research grants from AstraZeneca, unrelated to this work. All other authors report no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34764200</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pii">8/1/e001041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen J, Wu J, Hao S, et al. . Long term outcomes in survivors of epidemic influenza A (H7N9) virus infection. Sci Rep 2017;7:17275. 10.1038/s41598-017-17497-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17497-6</ArticleId><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Pasea L, Harris S, et al. . Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet 2020;395:1715&#x2013;25. 10.1016/S0140-6736(20)30854-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30854-0</ArticleId><ArticleId IdType="pmc">PMC7217641</ArticleId><ArticleId IdType="pubmed">32405103</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton A, Olliaro P, Sigfrid L, et al. . Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis 2021. :;21:00043&#x2013;8. Feb 3. 10.1016/S1473-3099(21)00043-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00043-8</ArticleId><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol 2021;20:1&#x2013;9. 10.1007/s12016-021-08848-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020. Available: https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: let patients help define long-lasting COVID symptoms. Nature 2020;586:170. 10.1038/d41586-020-02796-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK, 2021. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021</Citation></Reference><Reference><Citation>Altmann DM, Boyton RJ. Confronting the pathophysiology of long covid, 2020. BMJ opinion. Available: https://blogs.bmj.com/bmj/2020/12/09/confronting-the-pathophysiology-of-long-covid/</Citation></Reference><Reference><Citation>Madhavan S, Bastarache L, Brown JS, et al. . Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers. J Am Med Inform Assoc 2021;28:393&#x2013;401. 10.1093/jamia/ocaa287</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa287</ArticleId><ArticleId IdType="pmc">PMC7665546</ArticleId><ArticleId IdType="pubmed">33260207</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G, Long Covid Forum Group . Research priorities for long Covid: refined through an international multi-stakeholder forum. BMC Med 2021;19:84. 10.1186/s12916-021-01947-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, PHOSP-COVID Collaborative Group . Physical, cognitive and mental health impacts of COVID-19 following hospitalisation &#x2013; a multi-centre prospective cohort study. Medrxiv. 10.1101/2021.03.22.21254057v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254057v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-Month consequences of COVID-19 in patients discharged from Hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, et al. . Post-Acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis 2021;21:1373&#x2013;82. 10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS . NHS to offer &#x2018;long covid&#x2019; sufferers help at specialist centres, 2020. Available: https://www.england.nhs.uk/2020/10/nhs-to-offer-long-covid-help/</Citation></Reference><Reference><Citation>Park S, Elliott J, Berlin A, et al. . Strengthening the UK primary care response to covid-19. BMJ 2020;370:m3691. 10.1136/bmj.m3691</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3691</ArticleId><ArticleId IdType="pubmed">32978177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. . Developing services for long COVID: lessons from a study of wounded healers. Clin Med 2021;21:59&#x2013;65. 10.7861/clinmed.2020-0962</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0962</ArticleId><ArticleId IdType="pmc">PMC7850205</ArticleId><ArticleId IdType="pubmed">33479069</ArticleId></ArticleIdList></Reference><Reference><Citation>British Thoracic Society . British thoracic society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia, 2020.</Citation></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391. 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344&#x2013;9. 10.1016/j.jclinepi.2007.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: who calls on countries to offer patients more rehabilitation. BMJ 2021;372:n405. 10.1136/bmj.n405</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998;4:1241&#x2013;3. 10.1038/3218</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/3218</ArticleId><ArticleId IdType="pubmed">9809543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Plishka CT, Rotter T, Penz ED, et al. . Effects of clinical pathways for COPD on patient, professional, and systems outcomes: a systematic review. Chest 2019;156:864&#x2013;77. 10.1016/j.chest.2019.04.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.04.131</ArticleId><ArticleId IdType="pubmed">31150639</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, The OpenSAFELY collaborative . Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. medrxiV 2021. 10.1101/2021.05.06.21256755v2</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.06.21256755v2</ArticleId><ArticleId IdType="pmc">PMC8544137</ArticleId><ArticleId IdType="pubmed">34711574</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR . Living with covid-19. a dynamic review of the evidence around ongoing covid-19 symptoms (often called long covid), 2020. Available: https://evidence.nihr.ac.uk/themedreview/living-with-covid19</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H. Prospective case-control study of cardiovascular abnormalitiesCase-Control Study of Cardiovascular Abnormalities 6 months following mild covid-19 in healthcare workersMonths Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging 2021;14. 10.1016/j.jcmg.2021.04.011. [Epub ahead of print: 05 May 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan E, Cooper K, Cowie J, et al. . A national survey of community rehabilitation service provision for people with long Covid in Scotland. F1000Res 2020;9:1416. 10.12688/f1000research.27894.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27894.1</ArticleId><ArticleId IdType="pmc">PMC8063521</ArticleId><ArticleId IdType="pubmed">33953912</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, et al. . A multidisciplinary NHS COVID-19 service to manage Post-COVID-19 syndrome in the community. J Prim Care Community Health 2021;12:215013272110109. 10.1177/21501327211010994</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group, Horby P, Lim WS, et al. . Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384:693&#x2013;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MJ, Crawford JS, Geraghty KJ, et al. . The 'medically unexplained symptoms' syndrome concept and the cognitive-behavioural treatment model. J Health Psychol 2021:13591053211038042. 10.1177/13591053211038042</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053211038042</ArticleId><ArticleId IdType="pubmed">34554009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al. . Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>